BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3303001)

  • 1. High-dose metoclopramide and chlorpromazine in the treatment of cisplatin-induced emesis.
    Aasebø U; Slørdal L; Prytz PS; Aarbakke J
    Pharmacol Toxicol; 1987 May; 60(5):337-9. PubMed ID: 3303001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cisplatin drug therapy. Antiemetic treatment. Experiences with the use of high-dose metoclopramide combined with chlopromazine and prochlorperazine].
    Aasebø U; Myhr K
    Tidsskr Nor Laegeforen; 1985 Jan; 105(2):148-9. PubMed ID: 4038825
    [No Abstract]   [Full Text] [Related]  

  • 3. Effective control of moderate-dose cisplatin-induced emesis by a short-course regimen including metoclopramide, chlorpromazine and hydrocortisone: results of a randomized trial with metoclopramide alone.
    Pollera CF; Calabresi F
    Oncology; 1989; 46(4):238-44. PubMed ID: 2740067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiemetic efficacy of secobarbital and chlorpromazine compared to metoclopramide, diphenhydramine, and dexamethasone. A randomized trial.
    Richards PD; Flaum MA; Bateman M; Kardinal CG
    Cancer; 1986 Aug; 58(4):959-62. PubMed ID: 3521843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metoclopramide plus diphenhydramine compared with chlorpromazine in cisplatin-induced vomiting. Randomized, crossed and double-blind study].
    Alba E; Bastus R; Castro I; Ojeda B; de Andrés L
    Med Clin (Barc); 1987 Oct; 89(10):410-2. PubMed ID: 3682965
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
    Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Mae M; Fukuda M; Ohe Y; Sasaki S
    Jpn J Clin Oncol; 1989 Mar; 19(1):40-4. PubMed ID: 2921817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A randomized controlled trial of acute and delayed cisplatin-induced emesis with metoclopramide, dexamethasone and prochlorperazine].
    Nino S; Umehara H; Inoue I; Tamura T; Sasaki Y; Sakurai M; Shinkai T; Eguchi K; Saijo N; Suemasu K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2881-4. PubMed ID: 3310905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High doses of metoclopramide or droperidol in the prevention of cisplatin-induced emesis.
    Saller R; Hellenbrecht D
    Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1199-203. PubMed ID: 3545851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study.
    Gez E; Ben-Yosef R; Catane R; Brufman G; Biran S
    Oncology; 1989; 46(3):150-4. PubMed ID: 2654792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the antiemetic action of metoclopramide against cisplatin-induced emesis by transdermal electrical nerve stimulation.
    Saller R; Hellenbrecht D; Bühring M; Hess H
    J Clin Pharmacol; 1986 Feb; 26(2):115-9. PubMed ID: 3512620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benefit and risk of high-dose metoclopramide in comparison to high-dose haloperidol or triflupromazine in cisplatin-induced vomiting].
    Saller R; Hellenbrecht D
    Klin Wochenschr; 1985 May; 63(9):428-32. PubMed ID: 4039775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis.
    Hellenbrecht D; Saller R
    Arzneimittelforschung; 1986 Dec; 36(12):1845-9. PubMed ID: 3566848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of administration rate on cisplatin-induced emesis.
    Jordan NS; Schauer PK; Schauer A; Nightingale C; Golub G; Martin RS; Williams HM
    J Clin Oncol; 1985 Apr; 3(4):559-61. PubMed ID: 3884747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of high-dose metoclopramide in cancer patients receiving cisplatin therapy.
    McDermed JE; Cohen JL; Joseph C; Strum SB
    J Clin Oncol; 1985 Oct; 3(10):1400-8. PubMed ID: 3900303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of antiemetic effect of a metoclopramide-dexamethasone combination during subsequent cisplatin courses.
    Cognetti F; Carlini P; Pinnarò P; Ruggeri EM; Caporali C
    Oncology; 1986; 43(5):292-4. PubMed ID: 3763123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiemetic combination of metoclopramide and methylprednisolone for cisplatin-induced vomiting].
    Saito H; Amano H; Yasuda Y; Tsunekawa H; Fujimoto K; Yoshii S; Shimokata K
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1980-2. PubMed ID: 4051514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind comparison of the antiemetic effect of metoclopramide and lorazepam with or without dexamethasone in patients receiving high-dose cisplatin.
    Stephens SH; Silvey VL; Wheeler RH
    Cancer; 1990 Aug; 66(3):443-6. PubMed ID: 2194642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of four antiemetic regimens for the treatment of cisplatin-induced vomiting.
    Póka R; Hernádi Z; Juhász B; Lampé L
    Int J Gynaecol Obstet; 1993 Jul; 42(1):19-24. PubMed ID: 8103470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis.
    Saller R; Hellenbrecht D
    Cancer Treat Rep; 1985 Nov; 69(11):1301-3. PubMed ID: 3912040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.